Kurt Oreshack serves as Secretary and General Counsel at Maravai LifeSciences Holdings, Inc., a leading provider of life science reagents and services. In this role, he oversees all legal, compliance, and corporate governance functions, advising the executive team and board on strategic initiatives, regulatory matters, intellectual property protection, and risk management. Oreshack joined Maravai in 2021, bringing his deep expertise to support the company's rapid growth in the biotech sector, including its expansion following a successful public listing via SPAC merger in 2020. With more than 25 years of experience in life sciences and healthcare law, Oreshack previously held the position of Vice President and Deputy General Counsel at Quest Diagnostics Incorporated, the world's largest provider of diagnostic testing services. There, he led legal teams through complex mergers, acquisitions, and commercial transactions, while managing global compliance programs and high-stakes litigation. Earlier, as a partner in the life sciences practice at Covington & Burling LLP, he represented major pharmaceutical, biotech, and medical device companies in FDA regulatory proceedings, patent disputes, and multibillion-dollar deals. Oreshack's achievements include orchestrating key acquisitions at Quest Diagnostics that enhanced its market position and guiding Maravai through post-IPO challenges amid evolving industry regulations. A cum laude graduate of the University of Pennsylvania Carey Law School (J.D.) and the University of Notre Dame (B.A.), he is renowned for his strategic acumen, collaborative leadership, and commitment to fostering innovation within ethical and compliant frameworks.